Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Oct;30(4):521–527. doi: 10.1128/aac.30.4.521

Antibiotic tolerance among clinical isolates of bacteria.

E Tuomanen, D T Durack, A Tomasz
PMCID: PMC176473  PMID: 3539006

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard J. P., Francioli P., Glauser M. P. Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing. J Clin Invest. 1981 Oct;68(4):1113–1116. doi: 10.1172/JCI110337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Best G. K., Best N. H., Koval A. V. Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrob Agents Chemother. 1974 Dec;6(6):825–830. doi: 10.1128/aac.6.6.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brennan R. O., Durack D. T. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother. 1983 Feb;23(2):273–277. doi: 10.1128/aac.23.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broughton D. D., Mitchell W. G., Grossman M., Hadley W. K., Cohen M. S. Recurrence of group B streptococcal infection. J Pediatr. 1976 Aug;89(2):182–185. doi: 10.1016/s0022-3476(76)80441-6. [DOI] [PubMed] [Google Scholar]
  5. Brown M. R., Williams P. Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):7–14. doi: 10.1093/jac/15.suppl_a.7. [DOI] [PubMed] [Google Scholar]
  6. Brown M. R., Williams P. The influence of environment on envelope properties affecting survival of bacteria in infections. Annu Rev Microbiol. 1985;39:527–556. doi: 10.1146/annurev.mi.39.100185.002523. [DOI] [PubMed] [Google Scholar]
  7. Cozens R. M., Tuomanen E., Tosch W., Zak O., Suter J., Tomasz A. Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother. 1986 May;29(5):797–802. doi: 10.1128/aac.29.5.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Durack D. T., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest. 1973 Mar;52(3):592–598. doi: 10.1172/JCI107220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Durack D. T., Starkebaum M. K., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. J Lab Clin Med. 1977 Jul;90(1):171–179. [PubMed] [Google Scholar]
  10. Francioli P., Glauser M. P. Successful prophylaxis of experimental streptococcal endocarditis with single doses of sublethal concentrations of penicillin. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):297–302. doi: 10.1093/jac/15.suppl_a.297. [DOI] [PubMed] [Google Scholar]
  11. Francioli P., Moreillon P., Glauser M. P. Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci. J Infect Dis. 1985 Jul;152(1):83–89. doi: 10.1093/infdis/152.1.83. [DOI] [PubMed] [Google Scholar]
  12. Glauser M. P., Bernard J. P., Moreillon P., Francioli P. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis. 1983 Mar;147(3):568–575. doi: 10.1093/infdis/147.3.568. [DOI] [PubMed] [Google Scholar]
  13. Glauser M. P., Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis. 1982 Dec;146(6):806–810. doi: 10.1093/infdis/146.6.806. [DOI] [PubMed] [Google Scholar]
  14. Goessens W. H., Fontijne P., van Raffe M., Michel M. F. Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains. Antimicrob Agents Chemother. 1984 May;25(5):575–578. doi: 10.1128/aac.25.5.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldman P. L., Petersdorf R. G. Significance of methicillin tolerance in experimental staphylococcal endocarditis. Antimicrob Agents Chemother. 1979 Jun;15(6):802–806. doi: 10.1128/aac.15.6.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guze P. A., Kalmanson G. M., Guze L. B. The role of antibiotic tolerance in the response to treatment of pyelonephritis due to Staphylococcus aureus in rats. J Infect Dis. 1982 Feb;145(2):169–173. doi: 10.1093/infdis/145.2.169. [DOI] [PubMed] [Google Scholar]
  17. Handwerger S., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis. 1985 May-Jun;7(3):368–386. doi: 10.1093/clinids/7.3.368. [DOI] [PubMed] [Google Scholar]
  18. Hess J., Dankert J., Durack D. Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis. J Antimicrob Chemother. 1983 Jun;11(6):555–564. doi: 10.1093/jac/11.6.555. [DOI] [PubMed] [Google Scholar]
  19. Horne D., Tomasz A. Lethal effect of a heterologous murein hydrolase on penicillin-treated Streptococcus sanguis. Antimicrob Agents Chemother. 1980 Feb;17(2):235–246. doi: 10.1128/aac.17.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kitano K., Tomasz A. Escherichia coli mutants tolerant to beta-lactam antibiotics. J Bacteriol. 1979 Dec;140(3):955–963. doi: 10.1128/jb.140.3.955-963.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Krogstad D. J., Pargwette A. R. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother. 1980 Jun;17(6):965–968. doi: 10.1128/aac.17.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Liu H. H., Tomasz A. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis. 1985 Aug;152(2):365–372. doi: 10.1093/infdis/152.2.365. [DOI] [PubMed] [Google Scholar]
  23. Lowy F. D., Chang D. S., Neuhaus E. G., Horne D. S., Tomasz A., Steigbigel N. H. Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis. J Clin Invest. 1983 Mar;71(3):668–675. doi: 10.1172/JCI110813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lowy F. D., Neuhaus E. G., Chang D. S., Steigbigel N. H. Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis. Antimicrob Agents Chemother. 1983 Jan;23(1):67–73. doi: 10.1128/aac.23.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mayhall C. G., Medoff G., Marr J. J. Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin. Antimicrob Agents Chemother. 1976 Oct;10(4):707–712. doi: 10.1128/aac.10.4.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McDonald P. J., Craig W. A., Kunin C. M. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis. 1977 Feb;135(2):217–223. doi: 10.1093/infdis/135.2.217. [DOI] [PubMed] [Google Scholar]
  27. Moyed H. S., Bertrand K. P. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983 Aug;155(2):768–775. doi: 10.1128/jb.155.2.768-775.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Musher D. M., Fletcher T. Tolerant Staphylococcus aureus causing vertebral osteomyelitis. Arch Intern Med. 1982 Mar;142(3):632–634. [PubMed] [Google Scholar]
  29. Pelletier L. L., Jr, Durack D. T., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest. 1975 Aug;56(2):319–330. doi: 10.1172/JCI108096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pulliam L., Inokuchi S., Hadley W. K., Mills J. Penicillin tolerance in experimental streptococcal endocarditis. Lancet. 1979 Nov 3;2(8149):957–957. doi: 10.1016/s0140-6736(79)92649-7. [DOI] [PubMed] [Google Scholar]
  31. Rajashekaraiah K. R., Rice T., Rao V. S., Marsh D., Ramakrishna B., Kallick C. A. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med. 1980 Dec;93(6):796–801. doi: 10.7326/0003-4819-93-6-796. [DOI] [PubMed] [Google Scholar]
  32. Sabath L. D., Wheeler N., Laverdiere M., Blazevic D., Wilkinson B. J. A new type of penicillin resistance of Staphylococcus aureus. Lancet. 1977 Feb 26;1(8009):443–447. doi: 10.1016/s0140-6736(77)91941-9. [DOI] [PubMed] [Google Scholar]
  33. Scheld W. M., Zak O., Vosbeck K., Sande M. A. Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest. 1981 Nov;68(5):1381–1384. doi: 10.1172/JCI110388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Southwick F. S., Durack D. T. Chemotherapy of experimental streptococcal endocarditis. 3. Failure of a bacteriostatic agent (tetracycline) in prophylaxis. J Clin Pathol. 1974 Apr;27(4):261–264. doi: 10.1136/jcp.27.4.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Steinbrecher U. P. Serious infection in an adult due to penicillin-tolerant group B streptococcus. Arch Intern Med. 1981 Nov;141(12):1714–1715. [PubMed] [Google Scholar]
  36. Svenungsson B., Kalin M., Lindgren L. G. Therapeutic failure in pneumonia caused by a tolerant strain of Staphylococcus aureus. Scand J Infect Dis. 1982;14(4):309–311. doi: 10.3109/inf.1982.14.issue-4.13. [DOI] [PubMed] [Google Scholar]
  37. Tomasz A., Albino A., Zanati E. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature. 1970 Jul 11;227(5254):138–140. doi: 10.1038/227138a0. [DOI] [PubMed] [Google Scholar]
  38. Tuomanen E., Cozens R., Tosch W., Zak O., Tomasz A. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol. 1986 May;132(5):1297–1304. doi: 10.1099/00221287-132-5-1297. [DOI] [PubMed] [Google Scholar]
  39. Tuomanen E. Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors. J Bacteriol. 1986 Aug;167(2):535–543. doi: 10.1128/jb.167.2.535-543.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tuomanen E., Tomasz A. Induction of autolysis in nongrowing Escherichia coli. J Bacteriol. 1986 Sep;167(3):1077–1080. doi: 10.1128/jb.167.3.1077-1080.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wiggins G. L., Albritton W. L., Feeley J. C. Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother. 1978 May;13(5):854–860. doi: 10.1128/aac.13.5.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Williamson R., Tomasz A. Antibiotic-tolerant mutants of Streptococcus pneumoniae that are not deficient in autolytic activity. J Bacteriol. 1980 Oct;144(1):105–113. doi: 10.1128/jb.144.1.105-113.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES